4/15/2013

President Barack Obama's budget proposal would reduce biologic exclusivity from 12 years to seven, and it includes more than $160 billion in reduced spending that affects drugmakers. The plan would increase discounts for branded medications under Medicare Part D and reduce prices for drugs for people eligible for both Medicare and Medicaid.

Related Summaries